Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Srinivasan Shanmugam

Pharm. R&D Institute, Hanmi Pharm. Co., Ltd., Hwaseung-Si, Gyeonggi-Do, 445-913, Korea

Biography

Srinivasan Shanmugam, PhD has more than 20 years of experience in designing and development of conventional, NDDS/alternate, advanced/modified drug delivery systems, and pharmaceutical platform technologies for oral and other routes of administration. His expertise includes stability, solubility/dissolution, permeability, and bioavailability enhancement techniques/technologies for challenging drugs. Additionally, Dr Shanmugam has published numerous research articles, holds multiple patents, and is a reviewer/editorial member of various prestigious journals. In his current position, Dr Shanmugam is involved in the development and expansion of Adare’s pharmaceutical technology portfolio and facilitates product development and co-development opportunities.
Publications

Natural Bioenhancers: Current Outlook

Srinivasan Shanmugam

Editorial: Clin Pharmacol Biopharm 2015, 4:e116

DOI: 10.4172/2167-065X.1000e116

Peer-reviewed Full Article Peer-reviewed Article PDF

Top